These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 37333255

  • 21. ATF3 -activated accelerating effect of LINC00941/lncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1/HuR in pulmonary fibrosis.
    Zhang J, Wang H, Chen H, Li H, Xu P, Liu B, Zhang Q, Lv C, Song X.
    Autophagy; 2022 Nov; 18(11):2636-2655. PubMed ID: 35427207
    [Abstract] [Full Text] [Related]

  • 22. Atorvastatin attenuates pulmonary fibrosis in mice and human lung fibroblasts, by the regulation of myofibroblast differentiation and apoptosis.
    Yildirim M, Kayalar O, Atahan E, Oztay F.
    J Biochem Mol Toxicol; 2022 Jul; 36(7):e23074. PubMed ID: 35416377
    [Abstract] [Full Text] [Related]

  • 23. Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease.
    Harris WT, Kelly DR, Zhou Y, Wang D, MacEwen M, Hagood JS, Clancy JP, Ambalavanan N, Sorscher EJ.
    PLoS One; 2013 Jul; 8(8):e70196. PubMed ID: 23950911
    [Abstract] [Full Text] [Related]

  • 24. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
    Sobral LM, Montan PF, Zecchin KG, Martelli-Junior H, Vargas PA, Graner E, Coletta RD.
    J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic targeting of SRC kinase in myofibroblast differentiation and pulmonary fibrosis.
    Hu M, Che P, Han X, Cai GQ, Liu G, Antony V, Luckhardt T, Siegal GP, Zhou Y, Liu RM, Desai LP, O'Reilly PJ, Thannickal VJ, Ding Q.
    J Pharmacol Exp Ther; 2014 Oct; 351(1):87-95. PubMed ID: 25047515
    [Abstract] [Full Text] [Related]

  • 26. Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts.
    Zhang Q, Tu W, Tian K, Han L, Wang Q, Chen P, Zhou X.
    J Cell Biochem; 2019 Jan; 120(1):93-104. PubMed ID: 30230565
    [Abstract] [Full Text] [Related]

  • 27. Effect of IFN-gamma and dexamethasone on TGF-beta1-induced human fetal lung fibroblast-myofibroblast differentiation.
    Gu L, Zhu YJ, Guo ZJ, Xu XX, Xu WB.
    Acta Pharmacol Sin; 2004 Nov; 25(11):1479-88. PubMed ID: 15525471
    [Abstract] [Full Text] [Related]

  • 28. Anoctamin 1 calcium-activated chloride channel downregulates estrogen production in mouse ovarian granulosa cells.
    Sun M, Sui Y, Li L, Su W, Hao F, Zhu Q, Di W, Gao H, Ma T.
    Endocrinology; 2014 Aug; 155(8):2787-96. PubMed ID: 24823391
    [Abstract] [Full Text] [Related]

  • 29. Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β.
    Sandbo N, Lau A, Kach J, Ngam C, Yau D, Dulin NO.
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L656-66. PubMed ID: 21856814
    [Abstract] [Full Text] [Related]

  • 30. In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?
    Walraven M, Akershoek JJ, Beelen RH, Ulrich MM.
    Arch Dermatol Res; 2017 Mar; 309(2):111-121. PubMed ID: 28004279
    [Abstract] [Full Text] [Related]

  • 31. Critical role of serum response factor in pulmonary myofibroblast differentiation induced by TGF-beta.
    Sandbo N, Kregel S, Taurin S, Bhorade S, Dulin NO.
    Am J Respir Cell Mol Biol; 2009 Sep; 41(3):332-8. PubMed ID: 19151320
    [Abstract] [Full Text] [Related]

  • 32. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
    Usuki J, Matsuda K, Azuma A, Kudoh S, Gemma A.
    J Nippon Med Sch; 2012 Sep; 79(1):46-59. PubMed ID: 22398790
    [Abstract] [Full Text] [Related]

  • 33. Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts.
    Conte E, Gili E, Fagone E, Fruciano M, Iemmolo M, Vancheri C.
    Eur J Pharm Sci; 2014 Jul 16; 58():13-9. PubMed ID: 24613900
    [Abstract] [Full Text] [Related]

  • 34. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G, Karnati S, Vijayan V, Kotarkonda LK, Boateng E, Zhang W, Ruppert C, Günther A, Shi W, Baumgart-Vogt E.
    Proc Natl Acad Sci U S A; 2015 Apr 21; 112(16):E2048-57. PubMed ID: 25848047
    [Abstract] [Full Text] [Related]

  • 35. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
    Wu D, Lei H, Wang JY, Zhang CL, Feng H, Fu FY, Li L, Wu LL.
    J Mol Med (Berl); 2015 Dec 21; 93(12):1311-25. PubMed ID: 26138247
    [Abstract] [Full Text] [Related]

  • 36. A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis.
    Xu H, Yang F, Sun Y, Yuan Y, Cheng H, Wei Z, Li S, Cheng T, Brann D, Wang R.
    PLoS One; 2012 Dec 21; 7(7):e40301. PubMed ID: 22802960
    [Abstract] [Full Text] [Related]

  • 37. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1.
    Kono Y, Nishiuma T, Nishimura Y, Kotani Y, Okada T, Nakamura S, Yokoyama M.
    Am J Respir Cell Mol Biol; 2007 Oct 21; 37(4):395-404. PubMed ID: 17641298
    [Abstract] [Full Text] [Related]

  • 38. P120-catenin regulates pulmonary fibrosis and TGF-β induced lung fibroblast differentiation.
    Zhang Y, Jiao H, Wu Y, Sun X.
    Life Sci; 2019 Aug 01; 230():35-44. PubMed ID: 31125560
    [Abstract] [Full Text] [Related]

  • 39. Hypoxia Suppresses TGF-B1-Induced Cardiac Myocyte Myofibroblast Transformation by Inhibiting Smad2/3 and Rhoa Signaling Pathways.
    Yan Z, Shen D, Liao J, Zhang Y, Chen Y, Shi G, Gao F.
    Cell Physiol Biochem; 2018 Aug 01; 45(1):250-257. PubMed ID: 29357322
    [Abstract] [Full Text] [Related]

  • 40. Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis.
    Herrmann FE, Wollin L, Wirth J, Gantner F, Lämmle B, Wex E.
    Br J Pharmacol; 2017 Nov 01; 174(21):3848-3864. PubMed ID: 28810065
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.